Predictors and Complications of Blood Transfusion in Total Hip and Knee Arthroplasty
Section snippets
Methods
Under institutional review board (IRB) approval, a retrospective chart review was performed of clinical records from 1795 patients who underwent THA or TKA at our institution between January 1, 2011 and December 31, 2012. Data were collected from 6 fellowship trained surgeons at 2 academically affiliated hospitals. Five independent reviewers collected all data and performed extensive chart reviews. After excluding patients who underwent bilateral procedure, partial arthroplasty or revision
Results
Currently there are a variety of criteria used for calculating preoperative risk for adverse cardiac and pulmonary events preoperatively, including the revised cardiac risk index (RCRI) and cardiopulmonary risk index. Rather than focusing on cumulative risk assessment, we focused on individual variables including: age, gender, BMI, pre-operative Hbg, and preoperative creatinine. The final study group was 66.3% female. The average age was 66.2 years [standard deviation (SD) = 10.71], BMI = 31.94 kg/m2
Discussion
Despite several studies reporting on transfusion rates in TKA and THA, there is substantial variability in reported rates. Rate for TKA ranges from 3 to 67% and for THA from 4 to 68% 2., 4., 7., 12., 13., 14., 15.. One reason for the extreme variability in transfusion rates may be associated with the relative lack of clear consensus regarding the appropriate indications for transfusion. At our institution, we transfuse patients who are symptomatic with hemoglobin less than 8 mg/dL and
Acknowledgments
The authors would like to thank Michael Laker, MD, Jason Davis, MD and Robert Weir, MD for their continued support of this project. Additionally we recognize the contributions of Ed Peterson, PhD, Christopher Dobson, BS, Jakub Sikora-Klak, BS, Alexander Greenstein, BS.
References (20)
- et al.
Risks associated with blood transfusion after total knee arthroplasty
J Arthroplasty
(2004) - et al.
Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty
J Arthroplasty
(2010) - et al.
Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes
J Arthroplasty
(2013) - et al.
Blood transfusion strategies for total knee arthroplasty: minimizing autologous blood wastage, risk of homologous blood transfusion, and transfusion cost
J Arthroplasty
(1998) - et al.
Predicting need for allogeneic transfusion after total knee arthroplasty
J Arthroplasty
(2012) - et al.
Transfusion options in total joint arthroplasty
J Arthroplasty
(2002) - et al.
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030
J Bone Joint Surg
(2007) - et al.
An analysis of blood management in patients having a total hip or knee arthroplasty
J Bone Joint Surg
(1999) - et al.
Blood transfusions in orthopaedic operations
J Bone Joint Surg
(1996) - et al.
Blood transfusion costs: a multicenter study
Transfusion
(1991)
Cited by (0)
The Conflict of Interest statement associated with this article can be found at http://dx.doi.org/10.1016/j.arth.2014.03.048.